APA ציטוט

Noro, R., Seike, M., Zou, F., Soeno, C., Matsuda, K., Sugano, T., . . . Gemma, A. (2015). MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation. BMC Cancer.

Citação norma Chicago

Noro, Rintaro, et al. "MET FISH-positive Status Predicts Short Progression-free Survival and Overall Survival After Gefitinib Treatment in Lung Adenocarcinoma With EGFR Mutation." BMC Cancer 2015.

ציטוט MLA

Noro, Rintaro, et al. "MET FISH-positive Status Predicts Short Progression-free Survival and Overall Survival After Gefitinib Treatment in Lung Adenocarcinoma With EGFR Mutation." BMC Cancer 2015.